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Abstract
Background: Membrane proteins are an important class of proteins, playing a key role in many biological processes, 
and are a promising target in pharmaceutical development. However, membrane proteins are often difficult to 
produce in large quantities for the purpose of crystallographic or biochemical analyses.
Results: In this paper, we demonstrate that synthetic gene circuits designed specifically to overexpress certain genes 
can be applied to manipulate the expression kinetics of a model membrane protein, cytochrome bd quinol oxidase in 
E. coli, resulting in increased expression rates. The synthetic circuit involved is an engineered, autoinducer-independent 
variant of the lux operon activator LuxR from V. fischeri in an autoregulatory, positive feedback configuration.
Conclusions: Our proof-of-concept experiments indicate a statistically significant increase in the rate of production of 
the bd oxidase membrane protein. Synthetic gene networks provide a feasible solution for the problem of membrane 
protein production.
Background
One of the goals of the emerging discipline of synthetic
biology is to make it easy to 'reprogram' the behavior of
living organisms by transforming them with novel, ratio-
nally engineered, synthetic gene networks. Engineered
gene networks have numerous applications in diverse
biotechnological endeavors such as metabolic engineer-
ing [1,2], single cell biosensors [3,4] as well as cell-based
computers [5,6]. Precise regulation of gene expression
either through exogenous control or through endogenous
autoregulation is often critical for the development of
synthetic biology applications. Several strategies have
been developed for gene regulation including the devel-
opment of libraries with modified promoter sequences
[7], development of gene expression toggle switches con-
trolled by exogenous inputs [8], gene expression pulse
generators [9] and oscillators [10], and even post-tran-
scriptional regulatory systems [11]. There are numerous
reviews detailing the engineering principles behind the
development of synthetic gene circuits, recent advances,
and potential applications in the future [12-15].
Autoregulation by way of positive or negative feedback
is commonly used as a motif in gene regulatory circuits.
Depending on the specific circuit topology, feedback
often leads to improved performance of the gene regula-
tory circuits. Specifically, a positive feedback within the
regulatory circuit can lead to increased steady state level
(amplification) of the gene expression, faster response
kinetics, and increased sensitivity to exogenous inducers
or autoinducers [16-19]. These properties are particularly
suitable for applications such as protein production,
where the benefits of increased production rates can
directly translate into reduced resource costs and
increased profits.
While gene circuits are routinely used to express solu-
ble proteins such as green fluorescent protein (GFP) in
model circuits, they have not been applied for the pro-
duction of membrane proteins. The structure and bio-
chemistry of membrane proteins are extremely important
to study. About 20% of all genomes sequenced so far
appear to encode membrane proteins [20]. Additionally,
their key role in the etiology of many diseases make them
targets for therapeutic intervention. 60-70% of all drug
targets are membrane proteins, such as the G-protein
coupled receptor family [21,22].
Membrane proteins are very difficult to produce [22].
They are normally expressed at very low levels in nature.
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It is possible to express them at higher levels using strong
promoters such as the hybrid tac and trc promoters, or
high-activity polymerases such as the T7 RNA poly-
merase, however there are some inherent drawbacks with
these methods such as leaky expression or promoter tox-
icity. Additionally, heterologous expression of membrane
proteins can cause aggregation of the product within the
cells. These inclusion bodies have to be separated and
refolded in order to reconstitute their native structure.
This is often an inefficient and laborious process. We
note that there are recent developments in the field of
membrane protein expression, such as the development
of tunable T7 RNA polymerase-based systems (the so
called "Walker strains", C41(DE3) and C43(DE3)) that are
not significantly affected by T7 RNAP toxicity [23]. Posi-
tive feedback-based synthetic gene circuits offer an alter-
native to the gene expression techniques discussed above.
In this study, we explored the possibility of increasing the
expression of the model membrane protein, cytochrome
bd quinol oxidase (also referred to as bd oxidase), a termi-
nal oxidase from E. coli. Normally, bd  oxidase is
expressed under microaerobic conditions since it has a
high affinity to oxygen and serves as an oxygen scavenger
in low oxygen conditions [24,25]. Further, the biochemis-
try of bd oxidase is well-characterized, and methods to
measure the gene product levels spectrophotometrically
are well established [26]. These features make bd oxidase
a good test case to explore the positive feedback-based
gene expression system.
Materials and methods
Design of the synthetic gene network
A positive feedback circuit was built using elements from
the quorum sensing system in Vibrio fischeri and the bd
oxidase gene as shown in Figure 1. LuxR is a transcrip-
tional activator from the V. fischeri quorum sensing sys-
tem that binds to its cognate promoter plux and activates
expression of genes under its control. The wild type LuxR
i s  i n a c t i v e  w h e n  p r o d u c e d .  A c y l  h o m o s e r i n e  l a c t o n e
(AHL), produced by another gene, luxI, is an autoinducer
that binds LuxR and increases its activity. There are other
similar positive feedback circuits based on the wild type
LuxR, which rely on the action of AHL, either exoge-
nously supplied, or produced by the action of luxI, for
their expression system to operate correctly.
In our circuit, we specifically desired a regulatory pro-
tein that was not reliant on any external co-factors, and
operated independent of the cell density in the culture.
Fortunately, the structure-activity relationship of LuxR is
well-known. Previous studies have determined that an
Ala221TVal mutant of LuxR (denoted LuxR*) activates
the pluxpromoter even in the absence of AHL [19,27].
The gene network design consisted of two plasmids.
The first plasmid encoded a copy of the luxR* gene under
a constitutive promoter. The second plasmid encoded a
copy of the bd oxidase gene, along with another copy of
the luxR* gene in a bi-cistronic configuration. The two-
plasmid system was chosen to ensure modularity in
design and to ena ble t he facile c onstruction of e x peri-
mental controls to validate the positive feedback.
Selection of the host strain
E. coli strain ML15A is a bd oxidase knockout derivative
of the "Walker strain" C43 (DE3) (F-ompT hsdSB
() gal dcm cyd-), and was used as the host strain for
expressing the wild-type bd oxidase from a plasmid. It
has a tendency to overproduce membrane proteins [23].
All cloning work was performed by electroporation using
electrocompetent ML15A cells. The C43 (DE3) wild type
control does not have any plasmids, and has a chromo-
somal  bd oxidase gene, and was used as a control for
observing native expression of bd oxidase.
Plasmid construction
Plasmids pGN3, pKB1 and pKB2 were based on the
PRO™Tet6xHN bacterial expression system (Clontech
Laboratories, Mountain View, CA). The PRO™Tet6xHN
plasmid formed the basis of the plasmids constructed for
this experiment, which are described below.
Constitutive plasmid
The ColE1 origin from PRO™Tet6xHN was replaced by
p15A between the restriction sites XbaI and SacI as
described by Lutz and Bujard [28]. The chloramphenicol
resistance marker was replaced by the ampicillin resis-
tance marker (Apr) from pZE21 between the unique
restriction enzyme sites XhoI and SacI yielding pPRO-
TetE-Kan-p15A.
The  luxR*  gene was first amplified using primers
KW78F1 [AAC TTT ATA AGG AGG AAA AAC ATA
TGA AAA ACA TAA ATG CCG AC] and KW078R
[ACT GTC GAC TTA ATT TTT AAA GTA TGG GC].
rm BB
−−
Figure 1 A schematic showing the positive feedback-based gene 
expression system.
luxR*
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The resulting product was then amplified using primers
KW078F2 [TAT GAA TTC AAC TAA AGA TTA ACT
TTA TAA GGA GGA AAA ACA ] and KW078R to intro-
duce the EcoRI cut site (shown in boldface). This product
was then digested with EcoRI and SalI and sub-cloned
into the EcoRI and SalI cut-sites of pPROTetE-Kan-p15A.
KW079F [ATA GGT CTC TGT GCA AAT GAA ACT
CAA TAC AAC] and KW079R [ATA GGT CTC TGC
ACA TTG GTT AAA TGG AAA GTG A] were then used
to perform a whole plasmid PCR on the above to intro-
duce a mutation GCGTGTG (Ala221TVal) in luxR. The
resulting PCR product was then digested and blunt end
ligated with BsaI to obtain pGN3. The plasmid pGN3
thus consisted of the p15A origin of replication and the
ampicillin resistance marker (Apr) (Figure 2). It consists
of a copy of the luxR* gene under the control of the pro-
moter pLtetO-1. In the presence of the repressor TetR, this
promoter is tightly repressed, and can be induced by the
addition of anhydrotetracycline (aTc). However, the
ML15A host strain used in this experiment does not pro-
duce
TetR, and thus the luxR* gene is expressed constitu-
tively in the host. The pGN3 plasmid was used as the
constitutive plasmid (CP).
Feedback plasmid
pGN29 consists of a plasmid harboring the ColE1 origin
of replication, chloramphenicol resistance (Cmr), a green
fluorescent protein (gfp) and a copy of luxR* under the
control of the lux promoter (plux). The gfp  gene was
replaced by the bd oxidase gene producing the plasmid
pKB1. The bd oxidase gene was extracted from the pTY1
plasmid by PCR using the forward primer 5'(ATA GAA
TTC GCG ATG AGC AAG GAG TCA TG ATG TTA
GAT ATA GTC G)3' and the reverse primer 5'(ATT AAG
CTT CGC TTA GTA CAG AGA GTG GGT GTT ACG
TTC AAT ATC)3'. The forward primer contained an
EcoRI site (shown in boldface) and the reverse primer
contained HindIII site. pGN29 and the PCR product were
digested by using EcoRI and HindIII. The PCR product
obtained was ligated with the digested pGN29 to obtain
the positive feedback plasmid pKB1. The resulting 5.5 kb
plasmid was separated using gel electrophoresis.
No positive feedback control plasmid
Plasmid pGN23 consists of a ColE1 origin of replication,
chloramphenicol resistance and gfp  similar to pGN29.
However it contains a pLtetO-1  promoter, which was
replaced by the plux promoter. In addition, it does not
contain the luxR*  gene. The bd  oxidase region was
extracted from pTY1 using the same procedure as above,
and was similarly ligated with the pGN23 plasmid to
obtain the no positive feedback control plasmid pKB2.
The resulting plasmid was 4.7 kb.
All plasmids were verified using DNA sequencing. The
plasmid maps for pKB1, pKB2 and pGN3 are shown in
Figure 2. Table 1 shows a list of treatments and various
controls along with their designations.
Growth media
For all experiments, cells were grown in 5 ml of LB
medium (BD Bacto™Tryptone, BD Bacto™Yeast extract,
BD Bacto™agar, sodium chloride) with appropriate antibi-
otics (Sigma Aldrich, St. Louis, MO). Depending on the
plasmid's antibiotic resistance, a combination of 100 μg/
ml ampicillin and 34 μg/ml chloramphenicol was used.
Preparation of inoculum
The host strain with the appropriate plasmids was grown
initially in 5 ml culture tubes at 30°C in Gyrotory®water
bath shaker (Model G76, New Brunswick Scientific, Edi-
son, NJ) overnight in LB medium with the appropriate
antibiotics. 2 ml of the overnight culture was transferred
to 200 ml of fresh LB medium in 500 ml shake flasks with
the appropriate antibiotics and grown at 30°C for 10-12
hours, until the culture reached an optical density of
about 0.5.
Scale up and sampling
15 ml of the inoculum prepared as above was transferred
to each of the twenty four 2 l flasks containing 1 l LB
medium with the appropriate antibiotics. These flasks
were shaken at 220 rpm at 30°C using an Innova 4330
incubator shaker (New Brunswick Scientific, Edison, NJ).
Samples were taken at 4, 8, 10, 12, 16 and 20 h. At each
s a m p l i n g  t i m e  f o u r  2  l  f l a s k s  w e r e  r e m o v e d  f r o m  t h e
shaker and the cells were peletted at 11,220 × g for 20
min. The pellet was stored at -80°C until further use.
Figure 2 Schematics showing the different circuits tested. Plas-
mids pKB1(PF plasmid) and pKB2 (NPF control) are identical except for 
the absence of the luxR* element responsible for positive feedback on 
the latter. Plasmid pGN3 is the constitutive plasmid (CP).
ColE1 t0 Cmr pLuxI bd luxR* t1
pKB1 (Positive Feedback Plasmid)
ColE1 t0 Cmr pLuxI bd t1
pKB2 (No Positive Feedback Control)
p15A t0 Apr pLtetO-1 luxR* t1
pGN3 (Constitutively active plasmid)Bansal et al. Journal of Biological Engineering 2010, 4:6
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Protein sample preparation
The cell pellets were removed from -80°C and suspended
in 100 ml of cell lysis buffer (100 mM Tris, 15 mM ethyl-
enediaminetetraacetic acid (EDTA), 15 mM Benzami-
dine, pH 8.3). Deoxyribonuclease I (Sigma Aldrich, St.
Louis, MO) and protease inhibitor cocktail (P8465, Sigma
Aldrich, St. Louis, MO) were also added to the above sus-
pension. After the sample was completely suspended in
the buffer, cells were broken down by passing the sample
6 times through a nitrogen decompression based cell dis-
ruptor. The sample collected after disruption was then
centrifuged at 11,220 × g for 20 min and the pellet was
discarded. The supernatant was spun down in an ultra-
centrifuge (L7-65, Beckman Coulter, Fullerton, CA) at
125,000 × g for 4 h. The pellets were collected and stored
at -80°C until further processing. The membranes col-
lected for the different time intervals were then taken out
from the -80°C freezer and 0.5 g of each sample was
weighed out and solublized in 30 ml of buffer (50 mM
monopotassium phosphate, 25 mM potassium chloride, 5
mM ethylenediaminetetraacetic acid (EDTA), 0.75%
sucrose monododecanoate w/v, pH 6.5). The suspended
sample was spun down in an ultracentrifuge at 125,000 ×
g for 2 h and the supernatant was collected. The superna-
tant was used to find the concentration of heme d in each
sample by obtaining the absorbance spectrum of the sam-
ple.
Spectroscopic measurements
All of the absorbance spectra in the UV-Visible region
were obtained with a UV-Visible spectrophotometer
(8453, Agilent Technologies, Santa Clara, CA) using a 1-
cm path-length cuvette. For each sample, absorption
spectra were obtained for both air oxidized and reduced
heme d. The sample was reduced by adding sodium dithi-
onite in excess. Cytochrome bd oxidase has a chlorin
chromophore (heme D) exhibiting a characteristic
absorption maximum at 628 nm in the fully reduced
state. The bd oxidase concentration was determined from
the difference in the absorption spectra between dithion-
ite-reduced and air-oxidized bd oxidase levels using the
following equation [29]:
In this way, one can quantify the amount of active bd
oxidase in the membrane. The absorption at 607 nm is
not affected by bd oxidase and serves to eliminate any
artifacts due to baseline shifts in the absorbance spec-
trum.
Results and Discussion
Table 2 shows the results of the experiments. Each data
point corresponds to one reading of the level of bd oxi-
dase pooled from four 1 l culture flasks. All gene circuits
tested show bd oxidase levels that eventually rise above
the background expression level of the wild type. It is
expected that some of the cultures show bd oxidase levels
lower than wild type initially, because unlike the wild
type, the ML15A host strain is a bd oxidase knock out.
The wild type had an average concentration of 0.68 (±
0.31) μM of bd oxidase as compared to 3.05 (± 0.14) μM
for the two-plasmid systems. In addition, positive feed-
back has a significant effect on the kinetics of expression
of bd oxidase. Figure 3 shows the graph of bd oxidase
expression. In order to determine the statistical signifi-
cance of the results, the following form of the logistic
growth model was fitted to the data:
Here, [bd] is the concentration of bd oxidase in μM, A is 
the final asymptotic level of the growth curve, d is the 
time required for half-maximal expression, s is a scaling 
parameter and t is time in hours. This model captures all 
the parameters of interest of the positive feedback, 
including amplification (A), delay in expression (d), and 
system response kinetics (s). For the sample size of six 
data points per curve, the model parameters in Equation 
2 were computed using a non-linear fitting function pro-
Δ² 628 607
11 10 8 −
−− = nm mM cm . (1)
[] bd
A
e
dt
s
=
+
−
1
(2)
Table 1: Experimental design to test the effect of the positive feedback.
Circuits tested Key Remarks
pKB1+pGN3 PF+CP Treatment
pKB2+pGN3 NPF + CP Control to test the effect of positive feedback
pKB2 NPF Control to test the leakiness of the plux promoter
pKB1 PF Control to test the combined effect of the leakiness of the promoter and the positive feedback
N/A WT Control to test wild type expression levelsBansal et al. Journal of Biological Engineering 2010, 4:6
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vided by the open source statistical programming lan-
guage R®http://r-project.org. Table 3 shows the values of 
these parameters along with the statistics signifying the 
goodness-of-fit. Figure 4 shows the statistical comparison 
between the parameter values for the different circuits.
From the data and the computed model parameters
(Figures 3 and 4), it is clear that positive feedback has a
significant effect on the production kinetics of bd oxi-
dase. This behavior has been previously reported by sev-
eral researchers in literature for various cytosolic and
indicator proteins, and we confirm that it translates to the
expression of membrane proteins as well. Qualitatively,
our result is slightly different from previous work because
in this case, there is a steric limit on the amount of mem-
brane protein that can be produced, governed by the
amount of membrane itself. Since the asymptotic mem-
brane protein level is naturally capped, the membrane
localization kinetics appear to speed up.
Ideally, one would need replicates to determine the
varia bili ty  fr om  s am ple  t o sa m pl e  f or  ea c h of  t he  da ta
points. While replicates for each time point would have
led to greater confidence in the actual values of the model
parameters, as a series of six time points they are suffi-
cient to show that there exist significant statistical differ-
ences between the treatment and the various controls.
Moreover, the non-availability of the time points is a
result of the original problem: A large culture volume is
needed to produce a sample of membrane protein. In our
case, each time point is a pooled sample of four 1 l sam-
ples which leads to one measurable reading.
Nevertheless, within reason, certain conclusions can be
drawn. Firstly, all circuits tested produced more bd oxi-
dase than the wild type. This result was expected since bd
oxidase is typically expressed in microaerobic conditions,
whereas the conditions in our experiment were aerobic.
Secondly, all plasmids used were medium copy plasmids,
and by virtue of having multiple copies of the same gene,
one can expect a production level higher than that seen in
the wild type. Thirdly, the constitutive plasmid (i.e. the
constitutive promoter) plays a greater role in the final
level of gene expression rather than the positive feedback,
since there is no significant difference between the
asymptote parameter (A) of the treatment (PF+CP) and
the NPF+CP control, while there is a significant differ-
ence between the NPF+CP and the NPF controls. Finally,
the plux promoter, which is known to be leaky can cause
undesirable expression of the membrane protein, which
can lead to high expression levels if there is a positive
feedback available to amplify this leaky expression. This is
an important consideration when expressing toxic pro-
Table 2: Concentration in micromoles (μM) of bd oxidase produced by the various gene circuits.
Time Treatment Controls
(hrs) PF+CP NPF+CP PF onlY NPF only WT
4 1.050 0.663 0.487 0.173 0.483
8 2.838 1.354 0.601 0.101 0.715
10 3.114 1.670 0.537 0.411 0.582
12 2.983 1.848 1.040 1.184 0.655
16 2.766 2.154 1.443 1.274 0.932
20 3.052 2.701 1.627 1.373 0.763
Refer Table 1 for a description of the treatment and controls.
Figure 3 Kinetics of bd oxidase expression. Expression of bd oxi-
dase was measured every four hours. The expression system including 
both the constitutive plasmid (CP) and the positive feedback plasmid 
(PF) showed higher expression levels and faster expression kinetics 
than the controls. A logistic growth curve has been fitted to the read-
ings. For the wild type (WT), the horizontal line represents the average 
expression of bd oxidase over the experimental interval, with the dot-
ted lines enclosing the confidence interval for the mean.
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teins. The positive feedback really shows its benefits in
reducing the delay in producing the protein. In other
words, the positive feedback can reduce the time
required to saturate a membrane with membrane protein,
when viewed in comparison with the NPF+CP control.
However, the positive feedback might not be sufficient by
itself and requires a driver plasmid for maximum produc-
tivity.
The scaling parameter (s) gives an idea of the rate at
which a positive feedback can enable a circuit to switch
from the off state to the on state. As the scaling parameter
tends to zero, the switching behavior looks more 'digital',
i.e. with instantaneous switching between states. In this
case, the parameter values are difficult to interpret. The
treatment seems to have a high switching speed (low scal-
ing parameter value), but at the same time the NPF con-
trol also seems to have a similar behavior, which could be
a computational artifact due to the low final expression
level of bd oxidase in this case.
Table 3: Logistic growth model parameters for the experimental data.
Asymptote (A)
Circuit Estimate Std. Error p-value
PF+CP 2.9724 0.0722 2.08e-06
NPF+CP 2.6296 0.2365 0.000372
PF 1.9712 0.5349 0.0211
NPF 1.33029 0.06984 4.48e-05
WT* 0.68 0.155 2.9e-06
Delay (d)
Circuit Estimate Std. Error p-value
PF+CP 4.6043 0.3199 0.000135
NPF+CP 8.3328 1.0092 0.001174
PF 12.182 3.235 0.0197
NPF 10.55178 0.26399 2.34e-06
Scale (s)
Circuit Estimate Std. Error p-value
PF+CP 0.9892 0.4051 0.071
NPF+CP 3.5978 0.8644 0.0141
PF 4.6276 1.8552 0.0672
NPF 0.73923 0.21563 0.0266
For the WT, the average value was assumed to be the asymptotic value (A), while the delay and scale parameters were not estimated.
Figure 4 A statistical comparison of the logistic growth curve 
model parameters. The units for the Y-axis for the Asymptote (A) pa-
rameter are micromoles, whereas for delay (d) and scale (s) parameters 
have the units of hours. The error bars show two standard deviations 
on either side, representing the confidence intervals for the parameter 
values.
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Conclusions
One of the significant outcomes of the positive feedback
e x p r e s s i o n  s y s t e m  i s  t h a t  t h e  t i m e  r e q u i r e d  t o  r e a c h
steady state levels of bd oxidase membrane protein
reduces from 20 h (in the no feedback control case) to
about 8 h. There are, of course, several other factors that
determine the precise numerical values of this perfor-
mance gain, including promoter strength, plasmid copy
number and the specific strain used. While these experi-
ments do not have sufficient precision to quantify these
performance gains, they do show that the positive feed-
back-based system accrues statistically significant gains.
One of the goals of synthetic biology is to develop reus-
able gene regulatory systems. The positive feedback-
based system we have developed is modular and can be
readily extended as a building block in other protein
expression systems. It can also be used to enhance exist-
ing protein expression systems, which use inducible pro-
moters or exogenous polymerases such as T7 RNAP. It is
therefore an attractive alternative to increase the yields of
difficult-to-produce proteins such as membrane proteins.
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